Verteporfin in Photodynamic Therapy: Report no. 5 [1]

Ophthalmology

Volumn 111, Issue 11, 2004, Pages 2144-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

CLINICAL TRIAL; FOLLOW UP; HUMAN; LETTER; MYOPIA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SAFETY; STATISTICAL SIGNIFICANCE; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME;

CHOROIDAL NEOVASCULARIZATION; FOVEA CENTRALIS; HUMANS; MYOPIA; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RANDOMIZED CONTROLLED TRIALS; VISUAL ACUITY;

EID: 7444266253     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.08.002     Document Type: Letter

References (2)

1. Verteporfin in Photodynamic Therapy Study Group Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trialVIP report no. 1 Ophthalmology 108 2001 841 852
2. K.J. Blinder, M.S. Blumenkranz, N.M Bressler Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trialVIP report no. 3 Ophthalmology 110 2003 667 673